---
category: news
title: "Intron Health initiates research coverage of Xlife Sciences"
excerpt: "22.08.2022 / 07:00 CET/CEST Intron Health today published its first independent research report on Xlife Sciences (SIX: XLS). The coverage starts with a «Buy» rating and a target price of CHF 47. Intron Health has evaluated Veraxa Biotech AG, FUSE-AI ..."
publishedDateTime: 2022-08-22T05:20:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/intron-health-initiates-research-coverage-of-xlife-sciences-1031697040"
webUrl: "https://markets.businessinsider.com/news/stocks/intron-health-initiates-research-coverage-of-xlife-sciences-1031697040"
type: article
quality: 34
heat: 34
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - Facebook AI
  - AI

secured: "DAN01lWIaCsHugFNK8OQaJn6zm9lSE51SCokNHmH6QlchfhkBSARv6W4UmsT5jSaj68hr8nXtOKYFCoM6U00JC4xplgya/MtP3gxNf41hGjnntK6vtJcCnrVnSD8FZC7qdsgLXNW5NucyU3HZ0d+SFfIx8iFBpdE+nZXwhgmOVxtvAnpf9/P5HrEF83zInOrOE/XjmNvtqFs53E5UkWxUFrczHWlQFKoQ4sU/aWwr0JlqqHwaM9XaBZPmGiihb80V9uXGHVYu8X2YrgU9Rq7nNFnG8yOghl7Fr88A03HK3CTtB5QOUvW/lULWy4fSgKv08Ib6t6tXvdkEelO/oKrkt/1GfdBtySQcWvk6t0/LP0=;Tba8SZt6Z53tyS5DnJFYGQ=="
---

